1Woo KS, Qiao M, Chook P, et al. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention[J]. J Card Surg, 2002, 17(5): 432 -435.
2Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk[J]. N Engl J Med, 2003, 348(7): 593- 600.
3Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow - derived endothelial progenitor cells [ J ]. Circulation, 2002, 105 (25): 3017 -3024.
4Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expranded endothelial progenitor cells for therapeutic neovascularization[ J]. Proc Natl Acad Sci USA, 2000, 97(7): 3422 - 3427.
5Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease[J]. Circ Res, 2001, 89(1): E1-E7.
6Tepper OM, Galiano DR, Capla JM, et al. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures[J]. Circulation, 2002, 106: 2781- 2786.
7Welch GN, Loscalzo J. Homocysteine and atherothrombosis[J]. N Engl J Med, 1998, 338(15): 1042- 1050.
8Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis[J]. Science,1997, 275(5302): 964 - 967.
9Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR- 2 and AC133 by circulating human CD34+ cellsidentifies a population of functional endothelial precursors[J].Blood, 2000, 95(3): 952-958.
10Murayama T, Tepper OM, Silver M, et al. Determination of bone marrow- derived endothelial progenitor cell significance in angiogenic growth factor - induced neovascularization [ J ].Exp Hematol, 2002, 30(8): 967-972.
